Covasc Dosage & Drug Information

Concise Prescribing Info

Contents

Amlodipine besylate

Indications/Uses

1st-line treatment of HTN & myocardial ischemia whether due to fixed obstruction (stable angina) &/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculature.

Dosage/Direction for Use

HTN & angina Initially 5 mg once daily. Max: 10 mg.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity to dihydropyridines.

Special Precautions

Hepatic impairment. Pregnancy & lactation. Childn.

Adverse Reactions

Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitations, dizziness.

View ADR Monitoring Form

MIMS Class

Calcium Antagonists / Anti-Anginal Drugs

ATC Classification

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.

Regulatory Classification

Presentation/Packing

Form

Covasc tab 10 mg

Packing/Price

3 × 10's

Form

Covasc tab 5 mg

Packing/Price

3 × 10's

Covasc

amlodipine

Manufacturer:

Duopharma Manufacturing (Bangi)

Distributor:

Duopharma Marketing